IL129088A0 - Subepithelial turbidity inhibitor - Google Patents

Subepithelial turbidity inhibitor

Info

Publication number
IL129088A0
IL129088A0 IL12908897A IL12908897A IL129088A0 IL 129088 A0 IL129088 A0 IL 129088A0 IL 12908897 A IL12908897 A IL 12908897A IL 12908897 A IL12908897 A IL 12908897A IL 129088 A0 IL129088 A0 IL 129088A0
Authority
IL
Israel
Prior art keywords
subepithelial
haze
inhibitor
turbidity inhibitor
corneal subepithelial
Prior art date
Application number
IL12908897A
Other languages
English (en)
Original Assignee
Kissei Pharmaceutical
Nihon Tenganyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical, Nihon Tenganyaku Co Ltd filed Critical Kissei Pharmaceutical
Publication of IL129088A0 publication Critical patent/IL129088A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IL12908897A 1996-09-28 1997-09-24 Subepithelial turbidity inhibitor IL129088A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29222296 1996-09-28
PCT/JP1997/003371 WO1998013038A1 (fr) 1996-09-28 1997-09-24 Inhibiteur de turbidite sous-epitheliale

Publications (1)

Publication Number Publication Date
IL129088A0 true IL129088A0 (en) 2000-02-17

Family

ID=17779091

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12908897A IL129088A0 (en) 1996-09-28 1997-09-24 Subepithelial turbidity inhibitor

Country Status (10)

Country Link
US (1) US6180673B1 (es)
EP (1) EP0950409B1 (es)
KR (1) KR100509421B1 (es)
AT (1) ATE235900T1 (es)
AU (1) AU4397197A (es)
CA (1) CA2266363C (es)
DE (1) DE69720521T2 (es)
ES (1) ES2196366T3 (es)
IL (1) IL129088A0 (es)
WO (1) WO1998013038A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL132391A0 (en) * 1997-04-18 2001-03-19 Kissei Pharmaceutical Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
US9066912B2 (en) * 2003-11-17 2015-06-30 Ethicon, Inc. Drug-enhanced adhesion prevention
WO2006073126A1 (ja) * 2005-01-06 2006-07-13 Kissei Pharmaceutical Co., Ltd. 慢性移植片対宿主症におけるドライアイの予防および治療剤
KR101948156B1 (ko) * 2013-12-10 2019-02-14 인제대학교 산학협력단 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물
US11766421B2 (en) * 2017-09-25 2023-09-26 Surface Ophthalmics, Inc. Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
JP2632732B2 (ja) * 1989-11-06 1997-07-23 株式会社興人 Ｎ―（３’，４’―ジメトキシシンナモイル）アントラニル酸の製造方法
JPH05163222A (ja) * 1991-12-18 1993-06-29 Kissei Pharmaceut Co Ltd コラーゲン過剰合成疾患治療剤
EP0740549A1 (en) * 1994-01-21 1996-11-06 JAVITT, Jonathan C. Cis-hydroxyproline analogs for eye treatment
US6407139B1 (en) * 1996-02-15 2002-06-18 Kissei Pharmaceutical Co., Ltd. Neovascularization inhibitor

Also Published As

Publication number Publication date
ATE235900T1 (de) 2003-04-15
US6180673B1 (en) 2001-01-30
CA2266363C (en) 2007-05-22
WO1998013038A1 (fr) 1998-04-02
KR100509421B1 (ko) 2005-08-22
DE69720521D1 (de) 2003-05-08
DE69720521T2 (de) 2004-03-04
EP0950409B1 (en) 2003-04-02
KR20000048671A (ko) 2000-07-25
CA2266363A1 (en) 1998-04-02
ES2196366T3 (es) 2003-12-16
AU4397197A (en) 1998-04-17
EP0950409A1 (en) 1999-10-20
EP0950409A4 (en) 2001-04-11

Similar Documents

Publication Publication Date Title
FI950309A0 (fi) Proliiniamidijohdannaisia
AU653972B2 (en) HIV protease inhibitors
AU4438489A (en) Pharmaceutical compositions containing n-(3,4- dimethoxycinnamoyl)anthranilic acid
CA2396561A1 (en) Substituted oxazolidinones and their use in the field of blood coagulation
GR3032220T3 (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation
TW266154B (es)
DK0669912T3 (da) N-(3-Piperidinylcarbonyl)-beta-alaninderivater som PAF-antagonister
NO307689B1 (no) Anvendelse av et antimikrobielt middel
IL129088A0 (en) Subepithelial turbidity inhibitor
EA199900374A1 (ru) Ингибитор вторичной катаракты
HUT77135A (hu) Eljárás I típusú allergiás betegségek megelőzésére és kezelésére alkalmazható gyógyszerkészítmények előállítására
DE69421457D1 (de) Verwendung von N-(Pyridinyl)-1H-Indol-1-Aminen zur Herstellung eines Medikamentes zur Behandlung von zwangsneurotischen Erkrankungen
ATE352317T1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
DE69620573D1 (de) Mittel zur verminderung des augeninnendrucks
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE250413T1 (de) 2-aminotetraline zur behandlung von glaukom
AU7238994A (en) Succinamic acid compound, process for producing the same, and use thereof
AU1733101A (en) Benzamidine derivatives
RU99108789A (ru) Ингибитор субэпителиального помутнения роговицы
ZA929974B (en) Pharmaceutical composition for inhibiting the infection with AIDS virus